BiomX to Present at the 2024 RBC Capital Markets Global Healthcare Conference
May 06 2024 - 7:00AM
BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a
clinical-stage company advancing novel natural and engineered phage
therapies that target specific pathogenic bacteria, today announced
the company will participate in the RBC Capital Markets Global
Healthcare Conference in New York City on Wednesday, May 15, 2024.
Date & Time: Wednesday, May 15, 4:05 PM
ETFormat: Presentation and one-on-one
meetingsPresenter: Assaf Oron, Chief Business
Officer
The live webcast of the presentation will be accessible through
the Investors section of the Company’s website at
https://ir.biomx.com/news-events/ir-calendar. The webcast also will
be archived on the BiomX website for a period of 3 months.
About BiomX
BiomX is a clinical-stage company developing both natural and
engineered phage cocktails and personalized phage treatments
designed to target and destroy bacteria in the treatment of chronic
diseases. BiomX discovers and validates proprietary bacterial
targets and customizes phage compositions against these targets.
For more information, please visit www.biomx.com, the content of
which does not form a part of this press release.
BiomX, Inc.Assaf Oron+97254-2228901assafo@biomx.com